等待开盘 05-19 09:30:00 美东时间
+0.490
+1.81%
今日重点评级关注:Canaccord Genuity:维持Intellia Therapeutics"买入"评级,目标价从48美元升至58美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从7美元升至8美元
04-29 10:28
Piper Sandler analyst Nathan Race maintains HBT Finl (NASDAQ:HBT) with a Neutral and raises the price target from $30 to $32.
04-28 22:48
Companies Reporting Before The Bell • Alliance Res Partners (NASDAQ:ARLP) is es...
04-27 19:11
HBT Finl (NASDAQ:HBT) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.61 by 11.48 percent. This is a 11.48 percent increase over earnings of $0.61 per share from the same
04-27 19:07
HBT Financial, Inc. announced the appointment of Michael J. Morton to its Board of Directors and Heartland Bank's board, effective April 1, 2026. Morton, with nearly 40 years of banking experience, previously served as Vice Chair of U.S. Commercial Banking at BMO and Executive Vice President and Chief Credit Officer at MB Financial. Fred L. Drake, Executive Chairman, expressed confidence in Morton's leadership and expertise to contribute to the c...
03-25 11:05
今日重点评级关注:Piper Sandler:维持Allogene疗法"超配"评级,目标价从7美元升至8美元;B. Riley证券:维持Oncology Institute"买入"评级,目标价从6美元升至8美元
03-16 18:19
Piper Sandler analyst Nathan Race maintains HBT Finl (NASDAQ:HBT) with a Neutral and raises the price target from $29 to $30.
03-14 00:21
HBT Financial (HBT) on Wednesday announced the issuance and sale of $85 million in aggregate principal amount of Fixed-to-Floating Rate Subordinated Notes due 2036. The notes will bear interest at an...
03-12 04:40
HBT Financial, Inc. has issued and sold $85 million in Fixed-to-Floating Rate Subordinated Notes due 2036 in a private placement. The notes bear an initial fixed rate of 5.75% for five years, then reset quarterly to SOFR plus 233 basis points. HBT plans to use proceeds for general corporate purposes, potentially including share repurchases. Piper Sandler & Co. acted as placement agent, with Vedder Price and Barack Ferrazzano serving as counsel. T...
03-11 20:30